INSTITUTO DE OFTALMOBIOLOGÍA APLICADA (IOBA)
Institut
Hospital Universitario de Valme
Sevilla, EspañaPublikationen in Zusammenarbeit mit Forschern von Hospital Universitario de Valme (9)
2022
-
Novel genes and sex differences in COVID-19 severity
Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806
2019
-
Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behçet's Disease: National Multicenter Study of 177 Cases
Arthritis and Rheumatology, Vol. 71, Núm. 12, pp. 2081-2089
2018
-
Efficacy of Tocilizumab in Patients With Moderate-to-Severe Corticosteroid-Resistant Graves Orbitopathy: A Randomized Clinical Trial
American Journal of Ophthalmology, Vol. 195, pp. 181-190
-
Successful Optimization of Adalimumab Therapy in Refractory Uveitis Due to Behçet's Disease
Ophthalmology, Vol. 125, Núm. 9, pp. 1444-1451
2017
-
Prevalence of Vitreoretinal Interface Abnormalities on Spectral-Domain OCT in Healthy Participants over 45 Years of Age
Ophthalmology Retina
-
The protective association of endogenous immunoglobulins against sepsis mortality is restricted to patients with moderate organ failure
Annals of Intensive Care, Vol. 7, Núm. 1
2015
-
Anti-TNF-α therapy in refractory uveitis associated with sarcoidosis: Multicenter study of 17 patients
Seminars in Arthritis and Rheumatism, Vol. 45, Núm. 3, pp. 361-368
2014
-
A Delphi study to detect deficiencies and propose actions in real life treatment of neovascular age-related macular degeneration
Journal of Ophthalmology, Vol. 2014
-
EPICO 2.0 project. Development of educational therapeutic recommendations using the DELPHI technique on invasive candidiasis in critically ill adult patients in special situations
Revista Iberoamericana de Micologia, Vol. 31, Núm. 3, pp. 157-175